National Healthcare Properties (NASDAQ:NHP - Get Free Report) was upgraded by research analysts at Raymond James Financial to a "moderate buy" rating in a note issued to investors on Tuesday, Zacks reports.
A number of other equities analysts have also issued reports on the company. Wells Fargo & Company increased their price objective on National Healthcare Properties from $17.00 to $19.00 and gave the stock an "overweight" rating in a report on Tuesday, September 1st. Robert W. Baird lifted their target price on National Healthcare Properties from $17.00 to $18.00 and gave the company an "outperform" rating in a research note on Thursday, August 20th. Huntington started coverage on National Healthcare Properties in a research report on Friday, July 17th. They set an "outperform" rating and a $18.00 price target for the company. Weiss Ratings began coverage on National Healthcare Properties in a research report on Monday, July 20th. They set a "sell (d)" rating for the company. Finally, Royal Bank Of Canada increased their price target on National Healthcare Properties from $15.00 to $17.00 and gave the stock a "sector perform" rating in a research note on Monday, August 17th. Seven equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, National Healthcare Properties has an average rating of "Hold" and a consensus target price of $18.40.
Check Out Our Latest Report on National Healthcare Properties
National Healthcare Properties Price Performance
National Healthcare Properties stock opened at $15.51 on Tuesday. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.45. The firm's 50-day moving average price is $16.19. National Healthcare Properties has a 52-week low of $11.25 and a 52-week high of $17.46.
National Healthcare Properties (NASDAQ:NHP - Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported ($0.13) EPS for the quarter. The firm had revenue of $87.53 million during the quarter. National Healthcare Properties had a negative return on equity of 6.22% and a negative net margin of 13.04%. During the same period last year, the business posted ($0.85) EPS. Sell-side analysts anticipate that National Healthcare Properties will post 0.70 EPS for the current year.
Institutional Trading of National Healthcare Properties
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Copeland Capital Management LLC bought a new position in shares of National Healthcare Properties in the third quarter valued at approximately $90,000. Envestnet Asset Management Inc. acquired a new position in shares of National Healthcare Properties during the second quarter valued at approximately $366,000. State Street Corp acquired a new position in shares of National Healthcare Properties during the second quarter valued at approximately $8,975,000. The Manufacturers Life Insurance Company bought a new stake in National Healthcare Properties during the second quarter worth approximately $518,000. Finally, Squarepoint Ops LLC bought a new stake in National Healthcare Properties during the second quarter worth approximately $5,233,000.
About National Healthcare Properties
(
Get Free Report)
National Healthcare Properties, Inc was a U.S.-based real estate investment trust focused on healthcare-related properties. The company's portfolio consisted primarily of income-producing healthcare facilities, including skilled nursing centers, assisted-living communities, and other properties used by healthcare providers.
Its business model was based on acquiring healthcare real estate and leasing those properties to operators under long-term agreements. Through this approach, National Healthcare Properties sought to generate rental income from facilities serving aging and medically dependent populations.
National Healthcare Properties was historically associated with the U.S.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Healthcare Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Healthcare Properties wasn't on the list.
While National Healthcare Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.